Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Ekso Bionics Holdings (EKSO) over the last 12 years, with Q3 2025 value amounting to -$12000.0.

  • Ekso Bionics Holdings' Cash from Investing Activities fell 5000.0% to -$12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$83000.0, marking a year-over-year decrease of 4067.8%. This contributed to the annual value of -$37000.0 for FY2024, which is 7643.31% up from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' Cash from Investing Activities is -$12000.0, which was down 5000.0% from -$40000.0 recorded in Q2 2025.
  • Ekso Bionics Holdings' Cash from Investing Activities' 5-year high stood at $1000.0 during Q4 2021, with a 5-year trough of -$5.0 million in Q4 2022.
  • For the 5-year period, Ekso Bionics Holdings' Cash from Investing Activities averaged around -$417692.3, with its median value being -$21000.0 (2024).
  • As far as peak fluctuations go, Ekso Bionics Holdings' Cash from Investing Activities plummeted by 50350000.0% in 2022, and later skyrocketed by 9914.58% in 2023.
  • Ekso Bionics Holdings' Cash from Investing Activities (Quarter) stood at $1000.0 in 2021, then tumbled by 503500.0% to -$5.0 million in 2022, then skyrocketed by 99.15% to -$43000.0 in 2023, then skyrocketed by 51.16% to -$21000.0 in 2024, then skyrocketed by 42.86% to -$12000.0 in 2025.
  • Its last three reported values are -$12000.0 in Q3 2025, -$40000.0 for Q2 2025, and -$10000.0 during Q1 2025.